CTLT (catalent.com) Enterprise Value-to-Revenue Coefficient

Public company logo of Catalent (CTLT)

Catalent, Inc. (CTLT) is managed by international leadership with strict compliance controls and transparent auditing. Simultaneously, the CDMO behemoth is modernizing its plants by implementing renewable energy and reducing waste. The EV/Sales trend captures market emotional distortions, where shapes the current metric. The company's revenues are based on the contract manufacturing of biologics, injectables, and capsules for global pharmaceutical corporations.

CTLT Catalent, Inc Enterprise Value-to-Revenue Ratio (07/04/2022 - 11/20/2026)

CTLT (Catalent, Inc.): analytical breakdowns and indicator data

- current quotes and average value forecast:
Fundamental valuation:Catalent (CTLT)
Core merchandise of Catalent, Inc

Investors must filter out overvalued assets by analyzing EV/Sales, which compares the total enterprise value to annual revenue while excluding the impact of leverage. The current enterprise value-to-revenue ratio reflects the growth potential of Catalent, Inc. (CTLT) amid demand for obesity drugs, where low values confirm undervaluation and the high operational resilience of the CDMO model.